연구동향 분석

Clinical Factors Associated with Acquisition of Resistance to Levofloxacin in Stenotrophomonas maltophilia

백지현 한상훈 김창오 정수진 구남수 최준용 용동은 송영구 이경원 김준명 2014년

논문상세정보
인용/피인용
' Clinical Factors Associated with Acquisition of Resistance to Levofloxacin in Stenotrophomonas maltophilia' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • drug resistance
  • fluoroquinolones
  • levofloxacin
  • stenotrophomonas maltophilia
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,670 0

0.0%

' Clinical Factors Associated with Acquisition of Resistance to Levofloxacin in Stenotrophomonas maltophilia' 의 참고문헌

  • Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF
    Hernández A J Biol Chem 284 14428-14438 [2009]
  • Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment
    Abbott IJ Expert Rev Anti Infect Ther 9 471-488 [2011]
  • Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model
    Garrison MW Antimicrob Agents Chemother 40 2859-2864 [1996]
  • Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital
    Gülmez D Clin Microbiol Infect 11 880-886 [2005]
  • Stenotrophomonas maltophilia: an emerging global opportunistic pathogen
    Brooke JS Clin Microbiol Rev 25 2-41 [2012]
  • Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study
    Fihman V J Infect 64 391-398 [2012]
  • Stenotrophomonas maltophilia drug resistance
    Sanchez MB Future Microbiol 4 655-660 [2009]
  • Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance
    Alonso A Antimicrob Agents Chemother 44 1778-1782 [2000]
  • SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia
    Sánchez MB Antimicrob Agents Chemother 54 580-581 [2010]
  • Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia
    Tseng CC Infect Control Hosp Epidemiol 30 1193-1202 [2009]
  • Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009
    Araoka H Eur J Clin Microbiol Infect Dis 29 605-608 [2010]
  • Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer
    Ansari SR Cancer 109 2615-2622 [2007]
  • Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy
    Araoka H Transpl Infect Dis 14 355-363 [2012]
  • Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia
    Korakianitis I Int J Antimicrob Agents 36 387-389 [2010]
  • Plasmid-mediated quinolone resistance: an update
    Rodríguez-Martínez JM J Infect Chemother 17 149-182 [2011]
  • Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement
    CLSI - [2011]
  • Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia
    Gordon NC J Antimicrob Chemother 65 483-489 [2010]
  • Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system
    Zhang L Antimicrob Agents Chemother 44 287-293 [2000]
  • Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia
    Chang LL J Antimicrob Chemother 59 1038-1039 [2007]
  • In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods
    Nicodemo AC J Antimicrob Chemother 53 604-608 [2004]
  • Heterogeneous Spectrum of CFTR Gene Mutations in Korean Patients with Cystic Fibrosis
    정혜영 Annals of Laboratory Medicine 31 3 219-224 [2011]
  • Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes
    Toleman MA Emerg Infect Dis 13 559-565 [2007]
  • Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999)
    Gales AC Clin Infect Dis 32 Suppl 2 S104-S113 [2001]
  • Emergence of ofloxacin-resistant Citrobacter freundii and Pseudomonas maltophilia after ofloxacin therapy
    Cheng AF J Antimicrob Chemother 20 283-285 [1987]
  • Differential epigenetic compatibility of qnr antibiotic resistance determinants with the chromosome of Escherichia coli
    Sánchez MB PLoS One 7 e35149- [2012]
  • Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia
    Weiss K J Antimicrob Chemother 45 363-365 [2000]
  • Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia
    Lai CH J Microbiol Immunol Infect 37 350-358 [2004]
  • Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review
    Garazi M J Hosp Infect 81 114-118 [2012]
  • Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study
    Spanik S J Infect Chemother 5 180-184 [1999]
  • Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature
    Falagas ME Future Microbiol 4 1103-1109 [2009]
  • Antimicrobial therapy for Stenotrophomonas maltophilia infections
    Nicodemo AC Eur J Clin Microbiol Infect Dis 26 229-237 [2007]
  • Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli
    Sader HS Int J Antimicrob Agents 25 95-109 [2005]
  • Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains
    Valdezate S Antimicrob Agents Chemother 45 1581-1584 [2001]
  • Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections
    Farrell DJ Antimicrob Agents Chemother 54 2735-2737 [2010]